The Clinical and Regulatory Affairs team at HistoSonics is responsible for designing and overseeing clinical trials to evaluate the safety and efficacy of their innovative, non-invasive tissue destruction technology. This team ensures compliance with regulatory standards and facilitates communication with regulatory bodies, while also providing clinical education and support to ensure successful implementation of clinical studies.